APYX MEDICAL CORPORATION
Last · NasdaqGS$2.57-0.03 (-1.15%)close · yahoo · 14h ago
Market cap$108.26M42.1M sh
P/E · TTM-12.9fwd -10.2 · eps -0.20 · loss
Beta1.45vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.32$5.08
Volume38.7Ksession
| Revenue | $58.4M |
|---|---|
| Operating income | $-3.5M |
| Net income | $-5.4M |
| Free cash flow | $-4.2M |
| Operating margin | -6.1% |
| Net margin | -9.2% |
| Return on equity | -50.2% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-10
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -21.2%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -15.1%
- Accumulated Deficit High — Accumulated deficit / equity 613%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.09
Est. revenue
13.3M
Earnings transcripts
Documents
FormReporting forFiledFlags